Winson Y Cheung Selected Research

Pain (Aches)

6/2023	Improvement in patient-reported pain among patients with metastatic cancer and its association with opioid prescribing.
1/2023	Patient-Reported Symptom Burden and Supportive Care Needs of Patients With Stage II-III Colorectal Cancer During and After Adjuvant Systemic Treatment: A Real-World Evidence Study.
9/2020	Patient-level factors associated with chronic opioid use in cancer: a population-based cohort study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Winson Y Cheung Research Topics

Disease

68	Neoplasms (Cancer) 02/2024 - 03/2009
26	Colonic Neoplasms (Colon Cancer) 11/2022 - 06/2013
19	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 01/2012
13	Breast Neoplasms (Breast Cancer) 03/2024 - 07/2015
12	Pancreatic Neoplasms (Pancreatic Cancer) 02/2023 - 07/2017
10	Rectal Neoplasms (Rectal Cancer) 01/2022 - 06/2009
9	Melanoma (Melanoma, Malignant) 12/2023 - 01/2020
7	Neoplasm Metastasis (Metastasis) 01/2023 - 08/2013
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2019
6	Adenocarcinoma 12/2018 - 08/2009
5	Prostatic Neoplasms (Prostate Cancer) 03/2024 - 01/2018
5	Pathologic Complete Response 04/2023 - 12/2015
5	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 08/2014
3	Pain (Aches) 06/2023 - 09/2020
3	Disease Progression 12/2022 - 05/2009
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 10/2022 - 08/2013
3	Gastroesophageal Reflux (GERD) 09/2013 - 08/2009
2	Inflammation (Inflammations) 02/2024 - 01/2023
2	Hand-Foot Syndrome 02/2024 - 05/2022
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 01/2021
2	Neutropenia 12/2022 - 01/2019
2	Cardiotoxicity 05/2022 - 01/2021
2	Chronic Renal Insufficiency 12/2021 - 07/2015
2	Vomiting 01/2021 - 11/2014
2	Anemia 01/2021 - 08/2018
2	Lung Neoplasms (Lung Cancer) 10/2020 - 09/2020
2	Obesity 01/2020 - 06/2013
2	Second Primary Neoplasms (Neoplasms, Second) 01/2019 - 11/2017
2	Carcinoid Tumor (Carcinoid) 08/2018 - 08/2013
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 03/2016
2	Infections 08/2014 - 05/2007
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 08/2023
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 08/2023
1	Cancer Pain 06/2023
1	Amyloidosis 01/2023
1	Relapsing-Remitting Multiple Sclerosis 01/2023
1	Opiate Overdose 01/2023
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2023
1	Immunoglobulin Light-chain Amyloidosis 11/2022

Drug/Important Bio-Agent (IBA)

12	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2022 - 07/2008
10	Capecitabine (Xeloda)FDA Link 02/2024 - 03/2014
9	folfirinoxIBA 02/2023 - 07/2017
9	Gemcitabine FDA Link 02/2023 - 07/2017
8	Fluorouracil (Carac)FDA LinkGeneric 11/2022 - 12/2015
7	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2021
6	130-nm albumin-bound paclitaxelIBA 02/2023 - 07/2017
5	Opioid Analgesics (Opioids)IBA 06/2023 - 01/2019
5	NivolumabIBA 01/2023 - 01/2020
4	Bevacizumab (Avastin)FDA Link 10/2023 - 03/2016
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 08/2017
4	IpilimumabIBA 01/2023 - 10/2021
4	Leucovorin (Folinic Acid)FDA Link 10/2020 - 01/2018
4	Sorafenib (BAY 43-9006)FDA Link 01/2020 - 08/2014
3	Hormones (Hormone)IBA 03/2024 - 01/2018
3	pembrolizumabIBA 01/2023 - 01/2020
3	Octreotide (Sandostatin)FDA LinkGeneric 10/2022 - 08/2013
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 01/2018
3	DNA (Deoxyribonucleic Acid)IBA 09/2016 - 03/2009
3	Calcibiotic Root Canal SealerIBA 12/2014 - 04/2013
2	Celecoxib (Celebrex)FDA Link 02/2024 - 05/2022
2	Diclofenac (SR 38)FDA LinkGeneric 02/2024 - 05/2022
2	cabozantinibIBA 01/2023 - 01/2020
2	AlbuminsIBA 01/2023 - 07/2018
2	Amyloid (Amyloid Fibrils)IBA 01/2023 - 11/2022
2	PlatinumIBA 01/2023 - 10/2021
2	Programmed Cell Death 1 ReceptorIBA 12/2022 - 01/2020
2	Pemetrexed (MTA)FDA Link 06/2022 - 01/2022
2	regorafenibIBA 01/2020 - 06/2018
2	Indicators and Reagents (Reagents)IBA 01/2019 - 12/2015
2	Epidermal Growth Factor (EGF)IBA 01/2019 - 08/2009
2	ErbB Receptors (EGF Receptor)IBA 01/2018 - 02/2016
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2015 - 01/2013
1	Radium-223IBA 03/2024
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2024
1	insulin receptor-related receptor (IRR)IBA 12/2023
1	Biosimilar PharmaceuticalsIBA 10/2023
1	decitabine and cedazuridine drug combinationIBA 08/2023
1	PM 01183IBA 01/2023
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023
1	trifluridine tipiracil drug combinationIBA 12/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2022
1	B7-H1 AntigenIBA 11/2022
1	lanreotide (Somatuline)FDA Link 10/2022

Therapy/Procedure

55	Therapeutics 12/2023 - 05/2007
37	Drug Therapy (Chemotherapy) 01/2023 - 01/2007
25	Adjuvant Chemotherapy 12/2022 - 06/2009
12	Neoadjuvant Therapy 04/2023 - 12/2015
7	Immunotherapy 01/2023 - 01/2021
7	Radiotherapy 12/2021 - 01/2013
4	Aftercare (After-Treatment) 01/2023 - 05/2010
3	Castration 03/2024 - 12/2018
3	Ambulatory Care (Outpatient Care) 10/2023 - 01/2019
3	Chemoradiotherapy 01/2020 - 09/2014
2	Drug Tapering 12/2022 - 11/2022
2	Precision Medicine 01/2021 - 01/2018
2	Palliative Care (Palliative Therapy) 01/2021 - 03/2009
2	Combination Drug Therapy (Combination Chemotherapy) 01/2021 - 06/2020
2	Duration of Therapy 01/2019 - 01/2018
1	Metastasectomy 08/2023
1	Pain Management 06/2023